Announced Fri, 19 Jun · 10:40 IST
Invesco MF crosses 5 percent stake in Corona Remedies via open market
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.9%1-day move
₹1832.40
prior close
₹1845.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4+0.2+0.2+0.2+0.9+4.0+5.8+4.0+7.3+6.8+12.4+11.4——
Up moveDown movePending
AI summary
Invesco Mutual Fund, through six of its schemes, acquired 2,89,017 equity shares (0.47 percent) of Corona Remedies Ltd on June 17, 2026 through open market purchases. Its aggregate holding rose from 4.58 percent (28.03 lakh shares) to 5.06 percent (30.92 lakh shares), crossing the 5 percent disclosure threshold under SEBI SAST Regulations. The acquirer does not belong to the promoter group.
Likely market impact
FII buying interest signals institutional confidence; crossing 5 percent may trigger further disclosure obligations and add to demand pressure on the stock.